MAPT and frontotemporal dementia: In this study, we found that the FTD‐linked IVS 10+16 MAPT mutation impaired neuronal development and network functionality in 3D cortical organoids and explored the therapeutic potential of bezafibrate to promote mitochondrial biogenesis and counteract the effects of tau mutation.